Drreddys Laboratories | RDY - Net Income


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Drreddys Laboratories

Drreddys Laboratories reported INR9.59B in Net Income for its fiscal quarter ending in March of 2023.


Net Income Change
ANI Pharmaceuticals ANIP:US USD 1.44M 5.68M
Bayer BAYN:GR EUR 2.18B 1.57B
Cipla CIPLA:IN INR 5.26B 2.75B
Drreddys Laboratories RDY:US INR 9.59B 2.88B
Endo International ENDP:US USD -3279000 240.26M
GlaxoSmithKline GSK:LN GBP 1.49B 5M
Hikma Pharmaceutical HIK:LN USD 15M 158M
Horizon Pharma HZNP:US USD 54.68M 65.72M
Lonza Group LONN:SW CHF 723M 231M
Novartis NOVN:VX USD 2.29B 827M
Pacira PCRX:US USD -19536000 9.43M
Phibro Animal Health PAHC:US USD 10.04M 2.83M
Richter Gedeon RICHT:HB HUF 39.19B 79.62B
Sun Pharmaceuticals SUNP:IN INR 19.84B 1.82B
Supernus Pharmaceuticals SUPN:US USD 16.95M 8.53M
Teva Pharmaceutical Industries Ltd TEVA:IT USD -206000000 1.02B